Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: a Multi-omics Replication Study

Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.

Citing Articles

The Potential of Using Screening Tools for Bipolar Disorder to Predict Lithium Response.

Janiri D, Pinto M, Montanari S, Marzo E, Sfratta G, Donofrio G Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006081 PMC: 11859749. DOI: 10.3390/ph18020269.

Pharmacogenomics and response to lithium in bipolar disorder.

Paribello P, Isayeva U, Pisanu C, Squassina A, Manchia M Pharmacogenomics. 2025; 25(16-18):689-706.

PMID: 39998910 PMC: 11901374. DOI: 10.1080/14622416.2025.2470605.

Converging evidence for functional connections between the lithium response and PI3K-Akt signaling.

Dwyer D Transl Psychiatry. 2024; 14(1):458.

PMID: 39487122 PMC: 11530542. DOI: 10.1038/s41398-024-03160-y.

Identification of significant biomarkers for predicting the risk of bipolar disorder with arteriosclerosis based on integrative bioinformatics and machine learning.

Zheng X, Zhang X, Zhang Y, Chen C, Ji E Front Psychiatry. 2024; 15:1392437.

PMID: 39290304 PMC: 11405317. DOI: 10.3389/fpsyt.2024.1392437.

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review.

Krsek A, Ostojic L, Zivalj D, Baticic L Int J Mol Sci. 2024; 25(17).

PMID: 39273641 PMC: 11396210. DOI: 10.3390/ijms25179695.

References

Papiol S, Schulze T, Heilbronner U . Lithium response in bipolar disorder: Genetics, genomics, and beyond. Neurosci Lett. 2022; 785:136786. DOI: 10.1016/j.neulet.2022.136786. View

Talari K, Goyal M . Retrospective studies - utility and caveats. J R Coll Physicians Edinb. 2021; 50(4):398-402. DOI: 10.4997/JRCPE.2020.409. View

Wu C . Focal adhesion: a focal point in current cell biology and molecular medicine. Cell Adh Migr. 2009; 1(1):13-8. PMC: 2633675. DOI: 10.4161/cam.1.1.4081. View

Zhao W, Tobe B, Udeshi N, Xuan L, Pernia C, Zolg D . Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion. Transl Psychiatry. 2020; 10(1):76. PMC: 7039883. DOI: 10.1038/s41398-020-0753-6. View

Maletic V, Raison C . Integrated neurobiology of bipolar disorder. Front Psychiatry. 2014; 5:98. PMC: 4142322. DOI: 10.3389/fpsyt.2014.00098. View

Omotade O, Pollitt S, Zheng J . Actin-based growth cone motility and guidance. Mol Cell Neurosci. 2017; 84:4-10. PMC: 5587356. DOI: 10.1016/j.mcn.2017.03.001. View

Machado-Vieira R, Manji H, Zarate Jr C . The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 2009; 11 Suppl 2:92-109. PMC: 2800957. DOI: 10.1111/j.1399-5618.2009.00714.x. View

Szklarczyk D, Gable A, Nastou K, Lyon D, Kirsch R, Pyysalo S . The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2020; 49(D1):D605-D612. PMC: 7779004. DOI: 10.1093/nar/gkaa1074. View

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

10.

Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N . Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016; 387(10023):1085-1093. PMC: 4814312. DOI: 10.1016/S0140-6736(16)00143-4. View

11.

Mohamadian M, Fallah H, Ghofrani-Jahromi Z, Rahimi-Danesh M, Shokouhi Qare Saadlou M, Vaseghi S . Mood and behavior regulation: interaction of lithium and dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(7):1339-1359. DOI: 10.1007/s00210-023-02437-1. View

12.

Mishra H, Wei H, Rohr K, Ko I, Nievergelt C, Maihofer A . Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. Eur Neuropsychopharmacol. 2023; 74:1-14. PMC: 11801370. DOI: 10.1016/j.euroneuro.2023.04.009. View

13.

Konradi C, Zimmerman E, Yang C, Lohmann K, Gresch P, Pantazopoulos H . Hippocampal interneurons in bipolar disorder. Arch Gen Psychiatry. 2010; 68(4):340-50. PMC: 3197787. DOI: 10.1001/archgenpsychiatry.2010.175. View

14.

Jope R . Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci. 2003; 24(9):441-3. DOI: 10.1016/S0165-6147(03)00206-2. View

15.

Rajkowska G . Cell pathology in bipolar disorder. Bipolar Disord. 2002; 4(2):105-16. DOI: 10.1034/j.1399-5618.2002.01149.x. View

16.

Mertens J, Wang Q, Kim Y, Yu D, Pham S, Yang B . Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015; 527(7576):95-9. PMC: 4742055. DOI: 10.1038/nature15526. View

17.

Cipriani A, Hawton K, Stockton S, Geddes J . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ. 2013; 346:f3646. DOI: 10.1136/bmj.f3646. View

18.

Sajatovic M . Bipolar disorder: disease burden. Am J Manag Care. 2005; 11(3 Suppl):S80-4. View

19.

Gigante A, Young L, Yatham L, Andreazza A, Nery F, Grinberg L . Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol. 2011; 14(8):1075-89. DOI: 10.1017/S146114571000146X. View

20.

Niemsiri V, Rosenthal S, Nievergelt C, Maihofer A, Marchetto M, Santos R . Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis. Mol Psychiatry. 2023; 29(1):6-19. PMC: 11078741. DOI: 10.1038/s41380-022-01909-9. View